Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Active ongoing research into the roles of ubiquinol and D-ribose in HFpEF may provide clinicians with additional management opportunities. Ribose Experts Weigh in Bioenergy Life Science (BLS), the makers of a ribose energy ingredient, discussed the prospect of this clinical trial
Notably, these were men who previously didnt benefit from PDE5 inhibitor pills, so a one-third success rate in this hard-to-treat group was promising
It also helps maintain metabolism and to help regulate sleep cycles, an important function effecting weight loss
It may also be appealing for those navigating the financial barriers of traditional GLP-1 therapy
#DiabetesCare #PrecisionMedicine #MetabolicHealth #LowerTheDose #HealthcareInnovation To view or add a comment, sign in In our recent publication in Diabetes, Obesity and Metabolism, together with Professors Kokkinos and le Roux, we articulate a perspective grounded in robust scientific evidence, yet one that is rarely expressed with candor in the public scientific discourse: that, as with any other chronic disease, pharmacotherapy should constitute the central pillar in the treatment of obesity, while other approaches retain an important but complementary role
